Life360 director’s trust sells 4,000 company shares
Life360, Inc. director John Philip Coghlan reported open-market sales of company common stock executed through a related trust.
Rhea-AI Filing Summary
Life360, Inc. director John Philip Coghlan reported open-market sales of company common stock executed through a related trust. The John Coghlan Living Trust sold a total of 4,000 shares of Life360 common stock in two transactions on July 1, 2026, at weighted average prices of $56.04 and $56.57 per share, under a pre-arranged Rule 10b5-1 trading plan.
After these sales, the John Coghlan Living Trust held 24,431 shares of Life360 common stock. Related indirect holdings also include 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust, while direct holdings total 5,676 shares, including 4,840 restricted stock units that may convert into shares upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,000 shares
Net Sell
4 txns
Insider
COGHLAN JOHN PHILIP
Role
Director
Sold
4,000 shs ($224K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock | 3,798 | $56.04 | $213K |
| Sale | Common stock | 202 | $56.57 | $11K |
| holding | Common stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common stock — 24,431 shares (Indirect, Held by the John Coghlan Living Trust);
Common stock — 5,676 shares (Direct);
Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $56.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.52 to $56.67, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F4. Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Key Figures
Shares sold: 4,000 shares
Weighted average price (3,798 shares): $56.04 per share
Weighted average price (202 shares): $56.57 per share
+4 more
7 metrics
Shares sold
4,000 shares
Open-market sales on July 1, 2026
Weighted average price (3,798 shares)
$56.04 per share
Common stock sale by John Coghlan Living Trust
Weighted average price (202 shares)
$56.57 per share
Common stock sale by John Coghlan Living Trust
Trust holdings after sale
24,431 shares
Common stock held by John Coghlan Living Trust
Annuity trust holdings
55,494 shares
Common stock held by 2025 Grantor Retained Annuity Trust
Direct holdings
5,676 shares
Common stock held directly by reporting person
Restricted stock units
4,840 RSUs
Each RSU represents a contingent right to one share
Key Terms
Rule 10b5-1 trading plan, Grantor Retained Annuity Trust, weighted average price, restricted stock units
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Grantor Retained Annuity Trust financial
"Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
weighted average price financial
"The price reported in Column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
What insider transaction did Life360 (LIF) disclose in this Form 4?
Life360 reported that a trust associated with director John Philip Coghlan sold 4,000 shares of common stock. The sales were open-market transactions executed on July 1, 2026, and disclosed as part of his indirect ownership activity.
Were the Life360 (LIF) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on December 8, 2025. Such plans are pre-arranged and automatically execute trades according to a predetermined formula set when the insider lacked material nonpublic information.
What are the direct Life360 (LIF) holdings and restricted stock units for this insider?
The Form 4 shows 5,676 shares held directly by the reporting person, which include 4,840 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Life360 common stock upon vesting, as described in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
